Key player · Company profile

Alimera Sciences

Named as a key player in 33 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Diabetic Retinopathy Drugs (India) 9%

Where they show up

  • Pharmaceuticals33

Geographies

Alimera Sciences's markets

Markets where Alimera Sciences is a key player, with the world market size
MarketCategoryWorld 2023CAGR
Diabetic Retinopathy Drugs Pharmaceuticals$10.8 Bn6%

Companies they compete with most

Named as key players in the same markets as Alimera Sciences (number of shared markets).

AbbVie Inc.1 shared market Allergan (AbbVie Inc.)1 shared market Ampio Pharmaceuticals.1 shared market Bayer AG1 shared market Genentech Inc.1 shared market Novartis AG1 shared market Regeneron Pharmaceuticals1 shared market Roche Holding AG.1 shared market

Recent reports naming Alimera Sciences

Search all reports for Alimera Sciences All companies